Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “1- Women”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06145724
What this trial is testing

EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)

Who this might be right for
Maternal SepsisInfections
Columbia University 33,183
Not applicableUnknownNCT01967186
What this trial is testing

Intraportal or Intramuscular Site for Islets in Simultaneous Islet and Kidney Transplantation

Who this might be right for
Type 1 DiabetesEnd Stage Renal Disease
The Nordic Network For Clinical Islet Transplantation 36
Early research (Phase 1)Ended earlyNCT01891669
What this trial is testing

PF-06263507 In Patients With Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, Non Small Cell LungBreast Neoplasms+1 more
Pfizer 26
Early research (Phase 1)Ended earlyNCT05694169
What this trial is testing

Participants With Chronic Kidney Disease Previously Treated With REACT

Who this might be right for
Diabetic Kidney DiseaseCAKUTChronic Kidney Diseases
Prokidney 1
Large-scale testing (Phase 3)Ended earlyNCT01497197
What this trial is testing

A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique

Who this might be right for
InfertilityFertilityFollicle Stimulating Hormone Deficiency
Merck KGaA, Darmstadt, Germany 174
Testing effectiveness (Phase 2)Study completedNCT01999582
What this trial is testing

Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidney Disease on Hemodialysis

Who this might be right for
AnemiaKidney Failure, Chronic
Celgene 50
Early research (Phase 1)Looking for participantsNCT05614739
What this trial is testing

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Who this might be right for
Urinary Bladder NeoplasmsNeoplasm MetastasisUreteral Neoplasms
Eli Lilly and Company 677
Not applicableUnknownNCT04280757
What this trial is testing

Comparison Between Biopsied and Non-biopsied Intracytoplasmatic Sperm Injection (ICSI) Embryos and Natural Pregnancy Embryos

Who this might be right for
Women Conceiving by: 1- ICSI-PGS 2- ICSI-non-PGS 3- Spontaneously Conceiving Women
Wael Elbanna Clinic 420
Not applicableStudy completedNCT05022511
What this trial is testing

Three Birds With One Stone

Who this might be right for
Uterine Cervical CancerUterine Cervix CancerUterine Cervical Neoplasm+5 more
University of Aarhus 27,099
Early research (Phase 1)Study completedNCT00222872
What this trial is testing

3-Week Parathyroid Hormone-related Protein (PTHrP) Dose Escalation Study in Post-Menopausal Women

Who this might be right for
OsteoporosisOsteoporosis, Postmenopausal
University of Pittsburgh 61
Large-scale testing (Phase 3)Looking for participantsNCT06217302
What this trial is testing

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Who this might be right for
Diabetic NephropathiesKidney Failure, ChronicDiabetes Mellitus Type 1+1 more
Alessandro Doria 150
Early research (Phase 1)Study completedNCT06219902
What this trial is testing

Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women

Who this might be right for
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and MenHot Flashes
Bayer 64
Testing effectiveness (Phase 2)Study completedNCT04570839
What this trial is testing

COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

Who this might be right for
Endometrial NeoplasmsOvarian CancerSolid Tumor+1 more
Compugen Ltd 48
Not applicableStudy completedNCT00786019
What this trial is testing

Influence of Endothelial Function on Central and Peripheral Causes Of Exercise Impairment in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
University of Colorado, Denver 47
Testing effectiveness (Phase 2)Study completedNCT05575492
What this trial is testing

MRNA-1647 Cytomegalovirus Vaccine in Healthy Participants 9 to 15 Years of Age and Participants 16 to 25 Years of Age

Who this might be right for
Cytomegalovirus
ModernaTX, Inc. 873
Early research (Phase 1)Study completedNCT07388511
What this trial is testing

Elenestinib in Healthy Adult Female Participants

Who this might be right for
Healthy Participants
Blueprint Medicines Corporation 20
Testing effectiveness (Phase 2)Study completedNCT00776074
What this trial is testing

A Pharmacodynamic Study of Leuprorelin Gelatin-Free Formulation in Female Subjects With Uterine Fibroids.

Who this might be right for
Uterine Fibroids
Takeda 80
Early research (Phase 1)UnknownNCT06482541
What this trial is testing

Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia

Who this might be right for
Androgenetic Alopecia
Levit Dermatology 100
Testing effectiveness (Phase 2)WithdrawnNCT05483023
What this trial is testing

18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy

Who this might be right for
Complex Atypical HyperplasiaEndometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00274469
What this trial is testing

A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer

Who this might be right for
Metastatic Breast Cancer
AstraZeneca 205
Next Page